Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

Allurion Technologies today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume ...

Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced that it is relaunching the Allurion Balloon in France after ANSM, the French ...

This country research report on Vietnam Intra-gastric Balloons Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

NATICK, Mass. - Allurion Technologies, Inc. (NYSE: ALUR), a company focused on obesity treatment solutions, has expanded its intellectual property portfolio with a newly issued U.S. patent.

Pam Hodge weighed 350 pounds before Gastric Bypass Surgery, and workout transformation helped drop her weight to 119.

The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less TM ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...